Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins

Details for Australian Patent Application No. 2005295033 (hide)

Owner VIRxSYS Corporation

Inventors Garcia-Blanco, Mariano A.; McGarrity, Gerard J.

Agent Davies Collison Cave

Pub. Number AU-B-2005295033

PCT Pub. Number WO2006/042232

Priority 11/141,447 31.05.05 US; 60/617,324 08.10.04 US; 11/041,155 21.01.05 US

Filing date 7 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 19 January 2012

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/042232 Priority application(s): WO2006/042232

3 January 2008 Assignment before Grant

  Intronn, Inc. The application has been assigned to VIRxSYS Corporation

19 January 2012 Application Accepted

  Published as AU-B-2005295033

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295038-B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

2005295030-Method and system for loss-tolerant multimedia multicasting